Somatic Disease in Survivors of Childhood Malignant Bone Tumors in the Nordic Countries.
childhood malignant bone tumors
cohort study
late effects
somatic disease
survivorship
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
07 Sep 2021
07 Sep 2021
Historique:
received:
10
08
2021
revised:
02
09
2021
accepted:
03
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
Survivors of malignant bone tumors in childhood are at risk of long-term adverse health effects. We comprehensively reviewed cases of somatic diseases that required a hospital contact in survivors of osteosarcoma and Ewing sarcoma. In a population-based cohort study, 620 five-year survivors of osteosarcoma (n = 440) or Ewing sarcoma (n = 180), diagnosed before the age of 20 years in Denmark, Finland, Iceland, and Sweden during 1943-2008, were followed in the national hospital registers. Overall rates of hospital contacts for any somatic disease and for 12 main diagnostic groups and 120 specific disease categories were compared with those in a matched comparison cohort (n = 3049) randomly selected from the national population registers. The rate of hospital contact for any somatic disease was 80% higher in survivors of malignant bone tumors than in comparisons and remained elevated up to 30 years after diagnosis. The rate of hospital contacts was higher after Ewing sarcoma (rate ratio (RR) 2.24; 95% confidence interval (CI) 1.76-2.85) than after osteosarcoma (RR 1.67; 95% CI 1.41-1.98). Elevated rates were observed for 11 main diagnostic groups, including infections, second malignant neoplasms, and diseases of the skin, bones, and circulatory, digestive, endocrine, and urinary systems. Survivors of malignant bone tumors in childhood are at increased risk of somatic diseases many years after diagnosis. This comprehensive study contributes new insight into the risk of late effects in survivors of osteosarcoma and Ewing sarcoma, which is an essential basis for optimal patient counseling and follow-up care.
Identifiants
pubmed: 34572734
pii: cancers13184505
doi: 10.3390/cancers13184505
pmc: PMC8467516
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Børnecancerfonden
ID : 2014-48; 2015-32
Organisme : Barncancerfonden
ID : PR2014-0121
Organisme : Kræftens Bekæmpelse
ID : A7588
Références
J Clin Oncol. 1996 Oct;14(10):2818-25
pubmed: 8874344
J Natl Cancer Inst. 2010 Aug 18;102(16):1272-83
pubmed: 20656964
Cancer. 2017 Jul 1;123(13):2551-2560
pubmed: 28222219
Br J Cancer. 2015 Jun 9;112(12):1857-65
pubmed: 25989269
Pediatr Blood Cancer. 2012 Jul 15;59(1):126-32
pubmed: 22180128
N Engl J Med. 2006 Oct 12;355(15):1572-82
pubmed: 17035650
Eur J Cancer. 2008 May;44(7):983-91
pubmed: 18353632
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Cancer. 2012 Oct 15;118(20):5050-9
pubmed: 22415578
Scand J Public Health. 2012 Aug;40(6):505-15
pubmed: 22899561
J Pediatr Hematol Oncol. 1997 May-Jun;19(3):220-5
pubmed: 9201144
PLoS Med. 2017 May 9;14(5):e1002296
pubmed: 28486495
J Pediatr Hematol Oncol. 2006 Dec;28(12):774-80
pubmed: 17164644
Int J Epidemiol. 2015 Feb;44(1):324-33
pubmed: 25501468
Cancer. 2011 Feb 1;117(3):625-34
pubmed: 20922787
Cancer. 2005 Apr 1;103(7):1457-67
pubmed: 15712273
Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1280-9
pubmed: 24925676
Circulation. 2013 Oct 22;128(17):1927-95
pubmed: 24081971
Int J Cancer. 1987 Nov 15;40(5):620-4
pubmed: 3679589
J Pediatr Hematol Oncol. 2015 Apr;37(3):170-4
pubmed: 25089605
Br J Cancer. 2014 Mar 4;110(5):1342-50
pubmed: 24366296
Blood. 2007 Jan 1;109(1):46-51
pubmed: 16985182
J Natl Cancer Inst. 2010 Jul 21;102(14):1083-95
pubmed: 20634481
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
Am J Clin Oncol. 2017 Aug;40(4):423-428
pubmed: 25599318
Curr Opin Pediatr. 2009 Jun;21(3):365-72
pubmed: 19421061
J Clin Oncol. 2015 Sep 20;33(27):3036-46
pubmed: 26304893
Cancer. 2008 Nov 1;113(9):2597-604
pubmed: 18823030
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Pediatr Blood Cancer. 2015 Dec;62(12):2204-10
pubmed: 26193842
Cancer. 2002 Oct 15;95(8):1728-34
pubmed: 12365021
J Natl Cancer Inst. 2009 Jun 3;101(11):806-13
pubmed: 19470947